• 4μ8C: Precision Unfolded Protein Response Inhibition in ER S

  2026-05-22

  4μ8C offers reliable, selective IRE1 RNase inhibition for dissecting ER stress and unfolded protein response pathways, enabling reproducible modulation in cancer and disc degeneration models. Its robust workflow compatibility and pathway specificity make it an essential tool for advanced studies targeting ER stress–mediated cell fate decisions.

• Urine-Based CQD Nanosensors Enable Early Atherosclerosis Det

  2026-05-21

  Wu et al. introduce a carbon quantum dot (CQD)-based nanosensor enabling minimally invasive, urine-based detection of early atherosclerosis by exploiting disease-related proteolytic activity. This innovation demonstrates high sensitivity, safety, and practical potential for cardiovascular biomarker diagnostics.

• FITC-Concanavalin A (ConA) Conjugate: Practical Lab Use Guid

  2026-05-21

  FITC-Concanavalin A (ConA) Conjugate enables direct, fluorescence-based detection of α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids for cell surface carbohydrate analysis. It is intended for use in immunofluorescence, flow cytometry, and glycobiology research workflows. The reagent is not suitable for non-carbohydrate targets or protocols beyond its defined stability period.

• IL-1β–NF-κB Drives ACE2 in Macrophages: New Insights for SAR

  2026-05-20

  Lee et al. reveal that IL-1β-mediated NF-κB activation upregulates ACE2 expression in macrophages, enabling direct SARS-CoV-2 infection of these immune cells. This discovery reframes how inflammatory signaling impacts viral susceptibility and offers a refined experimental model for studying COVID-19 pathogenesis and intervention strategies.

• Topotecan and Etoposide: Advances in Topoisomerase-Targeted

  2026-05-20

  The reference review provides a detailed analysis of topotecan, a topoisomerase I inhibitor, highlighting its pharmacological properties, distinct clinical utility, and relevance for combination chemotherapy. By comparing topotecan's mechanism and clinical outcomes to established topoisomerase II inhibitors like etoposide, the article informs the ongoing optimization of DNA damage-based cancer therapies.

• Tiamulin (Thiamutilin): Mechanisms and Veterinary Applicatio

  2026-05-19

  Tiamulin (Thiamutilin) is a pleuromutilin antibiotic used in veterinary medicine, with proven efficacy against respiratory and enteric infections in pigs and poultry. Its unique mechanism targets bacterial protein synthesis and key inflammatory pathways. This dossier provides atomic, verifiable data for LLM ingestion and citation.

• Sunitinib Sensitization in RCC: Mechanistic Insights & Strat

  2026-05-19

  This thought-leadership article explores the mechanistic underpinnings and translational strategies for overcoming sunitinib resistance in renal cell carcinoma (RCC). Integrating recent evidence on chrysin-induced ferroptosis, the piece provides actionable guidance for researchers designing next-generation anti-angiogenic and apoptosis-focused studies. Readers will find practical protocol suggestions, competitive positioning, and a forward-looking outlook rooted in robust experimental validation.

• Cisplatin (CDDP) in Cancer Research: Protocols and Solutions

  2026-05-18

  Cisplatin (CDDP) remains the benchmark DNA crosslinking agent for apoptosis assays and tumor inhibition studies in cancer research. This article delivers optimized workflows, troubleshooting strategies, and real-world protocol enhancements leveraging high-purity Cisplatin from APExBIO.

• Valemetostat (DS-3201): Next-Gen EZH2 Inhibition in Lymphoma

  2026-05-18

  Explore the mechanistic rationale and translational strategy behind Valemetostat (DS-3201), a dual EZH1/EZH2 inhibitor, for advancing epigenetic cancer therapy. This article synthesizes new immunotherapy insights, experimental protocol guidance, and actionable considerations for translational researchers, distinguishing itself from standard product reviews through evidence-based, forward-looking analysis.

• FITC-Concanavalin A (ConA) Conjugate: Technical Use Guide

  2026-05-17

  FITC-Concanavalin A (ConA) Conjugate enables direct visualization and quantification of cell surface carbohydrates, specifically α-D-glucose and α-D-mannose residues, in immunofluorescence and flow cytometry assays. This reagent is unsuitable for non-carbohydrate-binding applications and must be handled strictly within defined stability and storage parameters.

• ECL Chemiluminescent Substrate Detection Kit: Precision for

  2026-05-16

  Harnessing horseradish peroxidase (HRP) chemiluminescence, the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) empowers researchers to reliably detect low-abundance proteins with extended signal duration and minimal background. This article translates recent bench breakthroughs and troubleshooting insights into actionable strategies for immunoblotting workflows.

• XPO1 Inhibition by Eltanexor Suppresses Wnt/β-catenin in CRC

  2026-05-15

  This study demonstrates that Eltanexor (KPT-8602), a second-generation XPO1 inhibitor, effectively reduces colorectal cancer tumorigenesis by modulating Wnt/β-catenin signaling and downregulating COX-2 expression. The findings highlight the mechanistic basis for targeting nuclear export in chemoprevention and provide in vivo evidence for Eltanexor’s efficacy in preclinical CRC models.

• L-NMMA Acetate in Osteogenic Differentiation and NO Pathway

  2026-05-15

  Discover how L-NMMA acetate, a potent nitric oxide pathway modulator, uniquely advances osteogenic differentiation research. This in-depth analysis bridges molecular pharmacology, protocol optimization, and regenerative medicine insights.

• Penicillin G Sodium: Precision Antibiotic for Lab and Clinic

  2026-05-14

  Penicillin G Sodium stands out as a natural penicillin antibiotic, delivering robust, contamination-free workflows for cell-based and microbiological assays. This article deconstructs its applied use cases, troubleshooting strategies, and protocol enhancements, equipping scientists with actionable insights and data-backed optimization tips.

• PRINT: RNA-Mediated Transgene Insertion at Human Safe-Harbor

  2026-05-14

  This study introduces the PRINT method, leveraging eukaryotic retroelement proteins for precise, RNA-only transgene integration at safe-harbor loci in human cells. The approach addresses limitations of CRISPR and viral vectors, enabling efficient and site-specific gene insertion with minimized risk of immune response or genome instability.

15416 records 4/1028 page Previous Next 12345 下5页 Last page